Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company.
Celmatix was recently awarded $3.5 million from the Advanced Research Projects Agency for Health (ARPA-H) through the Sprint for Women’s Health program. In this episode, Beim discusses how Celmatix will be using the funding.
To hear the full episode and learn more, click here:
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.